{"disease":{"id":"sle-systemic-lupus","name":"sle systemic lupus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04604990","title":"National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"King Saud University","has_results":false},{"nct_id":"NCT07087912","title":"Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":477,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT07136090","title":"OMERACT SLE Delphi","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT04866615","title":"Posterior Segment Evaluation of Patients With SLE Using OCT and OCTA","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Minia University","has_results":false},{"nct_id":"NCT07157202","title":"Associating Gastric Infection With Autoimmune Flare Severity in an Egyptians","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":115,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06971913","title":"Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT07077486","title":"Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT06610409","title":"Assessment of CXCL5 Level in SLE Patients and Its Correlation with Disease Activity","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06925542","title":"A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"CRISPR Therapeutics","has_results":false},{"nct_id":"NCT03142711","title":"Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Lupus Research Alliance","has_results":false},{"nct_id":"NCT04645225","title":"Clinical Characteristic and MEFV Gene Mutations in Patient With Juvenile Onest Systemic Lupus Erythematosus","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07274059","title":"Allogeneic UCB-derived CAR-T for SLE","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Chengdu Ucello Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT05866861","title":"A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Cugene Inc.","has_results":false},{"nct_id":"NCT07490041","title":"Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT07237659","title":"Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Neutrolis","has_results":false},{"nct_id":"NCT05624437","title":"BElimumab corticoSteroids Sparing Treatment in Systemic Lupus Erythematosus","phase":"","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Centre Hospitalier de Niort","has_results":false},{"nct_id":"NCT06560775","title":"Effects of Nigella Sativa on T Cells and Cytokine Profile in Pediatric SLE Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"University of Brawijaya","has_results":false},{"nct_id":"NCT07177911","title":"Safety and Efficacy Study of CC312 for Moderate to Severe SLE","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":32,"lead_sponsor_name":"CytoCares Inc","has_results":false},{"nct_id":"NCT06189157","title":"MB-CART19.1 in Refractory SLE","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":29,"lead_sponsor_name":"Miltenyi Biomedicine GmbH","has_results":false},{"nct_id":"NCT07516639","title":"First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":26,"lead_sponsor_name":"SUNHO（China）BioPharmaceutical CO., Ltd.","has_results":false},{"nct_id":"NCT07266337","title":"CD19/BCMA CAR-T for SLE","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Chengdu Ucello Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT06839976","title":"CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT06056921","title":"Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Chongqing Precision Biotech Co., Ltd","has_results":false},{"nct_id":"NCT07483346","title":"IASO-782 in Systemic Lupus Erythematosus","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Shanghai IASO Biotechnology Co., Ltd","has_results":false},{"nct_id":"NCT06548607","title":"Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Nanjing Bioheng Biotech Co., Ltd.","has_results":false},{"nct_id":"NCT06445127","title":"Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)","phase":"","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT07196072","title":"A Multi-component, Person-centered, and Yoga-based Coaching Program for Lupus Chronic Pain","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":15,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT07266090","title":"A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)","phase":"PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":15,"lead_sponsor_name":"Viatris Pharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT07315087","title":"CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT07193810","title":"A Study of CC312 for Relapsed/Refractory Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":6,"lead_sponsor_name":"CytoCares Inc","has_results":false},{"nct_id":"NCT06150651","title":"Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"Chulalongkorn University","has_results":false}],"total":31},"guidelines":[],"source":"Drug Landscape verified database"}